5 Stocks Are Center Stage Post Earnings

Incyte Corporation (NASDAQ:INCY) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $0.14 in the quarter versus EPS of $-0.44 in the year-earlier quarter. Revenue rose 294.08% to $113.85 million from the year-earlier quarter.

Incyte Corporation reported adjusted EPS income of $0.14 per share. By that measure, the company beat the mean analyst estimate of $-0.02. It beat the average revenue estimate of $92.03 million.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!

INCY

DaVita, Inc. (NYSE:DVA) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 7.69% to $1.68 in the quarter versus EPS of $1.57 in the year-earlier quarter. Revenue rose 33.05% to $2.48 billion from the year-earlier quarter.

DaVita, Inc. reported adjusted EPS income of $1.68 per share. By that measure, the company beat the mean analyst estimate of $1.6. It beat the average revenue estimate of $2.4 billion.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!

DVA

CryoLife Inc. (NYSE:CRY) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $0.08 in the quarter versus EPS of $0.07 in the year-earlier quarter. Revenue rose 7.89% to $32.8 million from the year-earlier quarter.

CryoLife Inc. reported adjusted EPS income of $0.08 per share. By that measure, the company beat the mean analyst estimate of $0.05. It missed the average revenue estimate of $33.58 million.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!

CRY

CONMED Corporation (NASDAQ:CNMD) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $0.52 in the quarter versus EPS of $0.46 in the year-earlier quarter. Revenue rose 8.42% to $201.2 million from the year-earlier quarter.

CONMED Corporation reported adjusted EPS income of $0.52 per share. By that measure, the company beat the mean analyst estimate of $0.50. It beat the average revenue estimate of $200.12 million.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!

CNMD

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased 0% to $0.6 in the quarter versus EPS of $0.41 in the year-earlier quarter. Revenue rose 40.84% to $320.5 million from the year-earlier quarter.

Alexion Pharmaceuticals, Inc. reported adjusted EPS income of $0.6 per share. By that measure, the company beat the mean analyst estimate of $0.53. It beat the average revenue estimate of $316.49 million.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!

ALXN
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.